OQROSign up free
Insider trade

Johnson & Johnson (JNJ): Officer sold ~$3.72M

Elizabeth Forminard, Officer at Johnson & Johnson, sold ~$3.72M of Johnson & Johnson shares.

~$3.72M
Approx. value · 13K sh @ $284.39
17K
Holds after · shares reported
Traded
Nov 12, 2026
Filed
Nov 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Apr 10, 2026Federal contract · $198K obligatedDepartment of Defense awarded Johnson & Johnson: $198K obligated to date
  2. Jul 7, 2026Federal contract · $168K obligatedDepartment of Defense awarded Johnson & Johnson: $168K obligated to date
  3. Jul 30, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date
  4. Sep 8, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Sep 17, 2026FDAFDA device clearance: HARMONIC 1100 Shears (HAR1120); HARMONIC 1100 Shears (HAR1136)
  6. Sep 18, 2026FDARecall: Automated Impella Controller, Packaged. Primary user control interface for the Impella Catheter, catheter-based heart pump.
  7. Sep 18, 2026FDARecall: Impella Optical Controller, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.
  8. Sep 18, 2026FDARecall: Impella Connect Optical AIC, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.
  9. Sep 23, 2026FDARecall: ETHILON Nylon Suture, Product Code 697G
  10. Sep 30, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  11. Oct 5, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date
  12. Oct 13, 2026Company filing · Form 8-K · ResultsReported its results
  13. Nov 5, 2026FDAFDA drug approval: Rybrevant Faspro
  14. Nov 12, 2026 · this disclosureInsiderOfficer sold ~$3.72M of JNJ shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 6 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Elizabeth Forminard, EVP, Chief Legal Officer

The full history of Elizabeth Forminard, EVP, Chief Legal Officer is on the profile page.

How this filing works

Explore the data

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data